P2‐531: A novel glycogen synthase kinase‐3 inhibitor 2‐methyl‐5‐(3‐{4‐[(s)‐methylsulfinyl]phenyl}‐1‐benzofuran‐5‐yl)‐1,3,4‐oxadiazole (mmbo) decreased tau phosphorylation and ameliorated cognitive deficits in a transgenic model of Alzheimer's disease

Subjects

Subjects :

Epidemiology
Health Policy
Oxadiazole
Pharmacology
Transgenic Model
Psychiatry and Mental health
Cellular and Molecular Neuroscience
chemistry.chemical_compound
1-benzofuran
Developmental Neuroscience
chemistry
GSK-3
Tau phosphorylation
Neurology (clinical)
Geriatrics and Gerontology

Details

ISSN :

15525279 and 15525260

Volume :

7

Database :

OpenAIRE

Journal :

Alzheimer's & Dementia

Accession number :

edsair.doi...........72fbacfd84d65b3f7144e024fe83008f

Full Text :

https://doi.org/10.1016/j.jalz.2011.05.1400